openPR Logo
Press release

Kidney Cancer Association Partners with Conquer Cancer Foundation to Fund Kidney Cancer Research

09-18-2018 01:12 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Pharma Ex. Markets

Pharma Healthcare

Pharma Healthcare

For over a decade, the Kidney Cancer Association has assisted with funding the Conquer Cancer Foundation of ASCO's Young Investigator Award. The award provides funding to promising doctors to pursue careers in kidney cancer research.

“Conquer Cancer truly appreciates the generous and ongoing support of the Kidney Cancer Association as we work together to advance cutting-edge research and treatments for kidney cancer. We value this partnership which supports kidney cancer research and education with the ultimate goal of helping patients and families affected by this disease,” said Nancy R. Daly, executive vice president and chief philanthropic officer of Conquer Cancer.

This year, the Kidney Cancer Association supported two awards through the Conquer Cancer Foundation.

Liam C. Macleod, M.D., M.P.H., of the University of Pittsburgh, who was one of the Young Investigator Award recipients, will study regionalization and its effect on patients. Regionalization is when specialized doctors, procedures, testing facilities and clinical trials tend to be concentrated at regional academic medical centers. This in turn, causes the patient to receive care far from home, increases out-of-pocket costs for patients and their families and it can result in miscommunication between local and regional medical providers, thus creating poor treatment results. The second part of the study will examine which factors make patients less likely to access a high-quality kidney cancer center.

"Receiving the Young Investigator Award allows for a year of protected time during my second year of urologic oncology fellowship training. I am passionate about improving access to high quality kidney cancer care. The resources provided by the Young Investigator Award will allow me to establish a solid foundation for long-term research and policy advocacy defining excellence in kidney cancer care across different stages of disease," Macleod said.

Lisa Derosa, M.D. of Gustave Roussy Cancer Campus and Paris Saclay University who was a Merit Award recipient supported by the Kidney Cancer Association, will use the grant to study the gut microbiome composition to predict resistance in renal cell carcinoma (RCC) patients on nivolumab.

“The Kidney Cancer Association provided me the opportunity to connect with top experts on kidney cancer and learn about new therapies,” Derosa said. “I want to become a contributive female oncologist in my field. For me, the Young Investigator Award is not an arrival but a step in the fight against the cancer.”

About the Kidney Cancer Association:
The Kidney Cancer Association is the world’s first international charity dedicated specifically to the eradication of death and suffering from renal cancers. It is also by far the largest kidney cancer charity, with members in more than 100 countries. We fund, promote and collaborate with the National Cancer Institute (NCI), American Society for Clinical Oncology (ASCO), American Urological Association (AUA) and other institutions on research projects. We educate families and physicians and serve as an advocate on behalf of patients at the state and federal levels in the United States and globally.

About the Conquer Cancer Foundation:
The Conquer Cancer Foundation was founded by the foremost cancer doctors of the American Society of Clinical Oncology (ASCO) to seek dramatic advances in the prevention, treatment, and cures of all types of cancer. ASCO was created in 1964 by seven cancer physicians with a single purpose: to improve the care of people with cancer. ASCO has grown from its original seven members to nearly 45,000 today representing over 120 countries. As its foundation, Conquer Cancer helps support ASCO's many programs and activities, including cancer research, learning opportunities for oncology professionals, patient and caregiver education, and more.

For News & Updates:

Pharma Ex. Markets is an independent business information and market analysis company that assists companies in the infrastructure industry through independent fact-based insight, ensuring their business success today and tomorrow.

Visit us:

727, 1st Cross,
Bangalore 560008

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Kidney Cancer Association Partners with Conquer Cancer Foundation to Fund Kidney Cancer Research here

News-ID: 1240839 • Views:

More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
Oncology Nutrition Market led to an unprecedented rise by 2025 : liver cancer, p …
Global Oncology Nutrition Market: Overview Cancer diagnosis creates myriad questions about diet and nutrition. Those pertain to if the food will make a patient feel sick to what should be ingested to fight cancer. This has spawned the oncology nutrition market which has been rising steadily due to the increasing cases of different types of cancer worldwide. During cancer treatment one needs to eat right in order to build up strength
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top